Literature DB >> 24900045

Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT.

William Makis1, Rajan Rakheja2, Josee Lavoie3, Marc Hickeson2.   

Abstract

Tetrasomy 8 is a relatively rare chromosomal abnormality that has been reported in only 33 cases in hematologic disorders. It is known for its association with aggressive acute myeloid leukemia (AML) and myeloid sarcoma and is considered a very poor prognostic factor. Myeloid sarcoma is a rare hematologic malignancy characterized by tumor masses consisting of immature myeloid cells, presenting at an extramedullary site. We present a case of a 17-year-old boy referred for an (18)F-FDG PET/CT for the evaluation of pleural masses and spinal bone lesions seen on CT, after presenting with a 4 month history of chest pain. The PET/CT revealed extensive FDG-avid extramedullary disease in the soft tissues of the chest, abdomen, and pelvis, which were biopsy-proven to be myeloid sarcoma, as well as extensive intramedullary disease biopsy proven to be AML. This is the first report of the use of (18)F-FDG PET/CT to stage a subset of aggressive AML and myeloid sarcoma in a patient with an associated chromosomal abnormality (tetrasomy 8).

Entities:  

Keywords:  Extramedullary AML; FDG; Fluorodeoxyglucose; Granulocytic sarcoma; Myeloid sarcoma; PET/CT; Tetrasomy 8

Year:  2012        PMID: 24900045      PMCID: PMC4042998          DOI: 10.1007/s13139-012-0128-x

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  21 in total

1.  Extramedullary acute myeloid leukemia and the use of FDG-PET/CT.

Authors:  Sonali Rao; Amelia Langston; James R Galt; Raghuveer K Halkar
Journal:  Clin Nucl Med       Date:  2009-06       Impact factor: 7.794

2.  Tetrasomy 8 and t(1;11)(p32;q24) in acute myelo-monocytic leukemia with extensive leukemic cutaneous involvement.

Authors:  F Ferrara; D Cancemi; P Friso; M Gaglione; A Picardi; L Rossi; M Scognamiglio
Journal:  Leuk Lymphoma       Date:  1996-02

Review 3.  Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.

Authors:  Valérie Beyer; Dominique Mühlematter; Valérie Parlier; Christine Cabrol; Sandrine Bougeon-Mamin; Max Solenthaler; Andreas Tobler; Paul Pugin; Michael Gregor; Felicitas Hitz; Urs Hess; Bernard Chapuis; France Laurencet; Urs Schanz; Pierre-Michel Schmidt; Guy van Melle; Martine Jotterand
Journal:  Cancer Genet Cytogenet       Date:  2005-07-15

4.  Tetrasomy of chromosome 8: an interesting and rare cytogenetic phenomenon in acute nonlymphocytic leukemia.

Authors:  S N Jani Sait; A Raza; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1987-08

5.  Tetrasomy 8 in acute monoblastic leukemia (AML-M5a) with myelosarcomatosis of the skin.

Authors:  C Marosi; M Muhm; A Argyriou-Tirita; H Pehamberger; H Pirc-Danoewinata; K Geissler; G Locker; N Grois; O A Haas
Journal:  Cancer Genet Cytogenet       Date:  1993-11

6.  FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment.

Authors:  Masatoyo Nakajo; Seishi Jinnouchi; Hirosaka Inoue; Maki Otsuka; Tadashi Matsumoto; Toshimasa Kukita; Hiroaki Tanabe; Rie Tateno; Masayuki Nakajo
Journal:  Clin Nucl Med       Date:  2007-10       Impact factor: 7.794

7.  Localized relapse in bone marrow of extremities after allogeneic stem cell transplantation for acute lymphoblastic leukemia.

Authors:  T Endo; N Sato; K Koizumi; M Nishio; K Fujimoto; T Sakai; K Kumano; M Obara; K Minauchi; T Koike
Journal:  Am J Hematol       Date:  2004-07       Impact factor: 10.047

8.  F-18 FDG PET/CT showing bilateral breast involvement in acute myeloid leukemia relapse.

Authors:  Christian von Falck; Florian Laenger; Wolfram H Knapp; Michael Galanski
Journal:  Clin Nucl Med       Date:  2009-10       Impact factor: 7.794

9.  Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

Authors:  Patrice Chevallier; Mohamad Mohty; Bruno Lioure; Gerard Michel; Nathalie Contentin; Eric Deconinck; Pierre Bordigoni; Jean-Paul Vernant; Mathilde Hunault; Stéphane Vigouroux; Didier Blaise; Reza Tabrizi; Agnes Buzyn; Gerard Socie; Mauricette Michallet; Christelle Volteau; Jean-Luc Harousseau
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

10.  Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Initial results.

Authors:  P Aschoff; M Häntschel; M Oksüz; M K Werner; M Lichy; W Vogel; C Pfannenberg
Journal:  Nuklearmedizin       Date:  2009-08-27       Impact factor: 1.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.